| Primary |
| Drug Use For Unknown Indication |
34.0% |
| Asthma |
28.1% |
| Product Used For Unknown Indication |
10.7% |
| Chronic Obstructive Pulmonary Disease |
9.9% |
| Hypertension |
2.6% |
| Bronchitis Chronic |
1.8% |
| Depression |
1.3% |
| Interstitial Lung Disease |
1.3% |
| Cough |
1.2% |
| Osteoporosis |
1.2% |
| Suicide Attempt |
1.2% |
| Immunosuppression |
1.0% |
| Pneumonia Mycoplasmal |
1.0% |
| Bronchitis |
0.7% |
| Cancer Pain |
0.7% |
| Convulsion |
0.7% |
| Hypothyroidism |
0.7% |
| Nasopharyngitis |
0.7% |
| Pneumonia |
0.7% |
| Polycythaemia |
0.7% |
|
| Status Epilepticus |
30.1% |
| Vomiting |
15.8% |
| Tachycardia |
7.7% |
| Rhabdomyolysis |
6.1% |
| Ventricular Fibrillation |
4.1% |
| Wheezing |
4.1% |
| Gynaecomastia |
3.1% |
| Tachyarrhythmia |
3.1% |
| Viral Infection |
2.6% |
| Vitamin B6 Decreased |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Anaphylactic Reaction |
2.0% |
| Drug Interaction |
2.0% |
| Malaise |
2.0% |
| Medication Error |
2.0% |
| Multiple Drug Overdose |
2.0% |
| Pulmonary Oedema |
2.0% |
| Suicidal Ideation |
2.0% |
| Tonic Convulsion |
2.0% |
| Unevaluable Event |
2.0% |
|
| Secondary |
| Asthma |
16.5% |
| Drug Use For Unknown Indication |
14.4% |
| Chronic Obstructive Pulmonary Disease |
13.9% |
| Product Used For Unknown Indication |
11.6% |
| Hypertension |
7.4% |
| Intentional Overdose |
5.8% |
| Bacteraemia |
4.2% |
| Osteoporosis |
2.9% |
| Sedation |
2.8% |
| Prophylaxis |
2.6% |
| Atrial Fibrillation |
2.3% |
| Depression |
2.2% |
| Cardiac Disorder |
2.0% |
| Emphysema |
1.9% |
| Coronary Artery Disease |
1.9% |
| Alcohol Withdrawal Syndrome |
1.9% |
| Thrombosis Prophylaxis |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Mucous Membrane Disorder |
1.4% |
| Epilepsy |
1.3% |
|
| Toxic Epidermal Necrolysis |
17.6% |
| Malignant Neoplasm Progression |
13.6% |
| Vomiting |
9.6% |
| Rhabdomyolysis |
8.6% |
| Tachycardia |
7.4% |
| Neuroleptic Malignant Syndrome |
3.7% |
| Sinusitis |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Respiratory Depression |
3.4% |
| Pruritus |
3.1% |
| Small Intestinal Perforation |
3.1% |
| Completed Suicide |
2.8% |
| Drug Toxicity |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Death |
2.5% |
| Dyspnoea |
2.5% |
| Pyrexia |
2.5% |
| Sepsis |
2.5% |
| Overdose |
2.2% |
| Tonic Convulsion |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.7% |
| Product Used For Unknown Indication |
18.9% |
| Asthma |
17.7% |
| Chronic Obstructive Pulmonary Disease |
11.7% |
| Hypertension |
5.4% |
| Pain |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Osteoporosis |
2.2% |
| Diabetes Mellitus |
1.9% |
| Depression |
1.9% |
| Emphysema |
1.8% |
| Prophylaxis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Bronchitis |
1.2% |
| Dyspnoea |
1.2% |
| Smoking Cessation Therapy |
1.1% |
| Cardiac Failure |
1.0% |
| Pneumonia |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
| Anxiety |
0.9% |
|
| Vomiting |
11.5% |
| Pneumonia |
8.4% |
| Weight Decreased |
7.8% |
| Dyspnoea |
7.1% |
| Asthma |
6.8% |
| Weight Increased |
5.9% |
| Wheezing |
5.8% |
| Death |
5.4% |
| Drug Ineffective |
5.3% |
| Pyrexia |
4.1% |
| Nausea |
3.9% |
| Tremor |
3.6% |
| Respiratory Failure |
3.6% |
| Urticaria |
3.5% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Product Quality Issue |
3.1% |
| Pain |
2.8% |
| Pharmaceutical Product Complaint |
2.8% |
| Myocardial Infarction |
2.7% |
| Rash |
2.7% |
|
| Interacting |
| Chronic Obstructive Pulmonary Disease |
15.4% |
| Hypertension |
12.8% |
| Drug Use For Unknown Indication |
8.0% |
| Pain |
8.0% |
| Asthma |
5.9% |
| Restlessness |
5.9% |
| Sleep Disorder |
5.9% |
| Emphysema |
5.3% |
| Ischaemic Heart Disease Prophylaxis |
4.8% |
| Osteoporosis |
4.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.8% |
| Immunosuppressant Drug Therapy |
3.7% |
| Product Used For Unknown Indication |
3.7% |
| Breast Cancer Metastatic |
2.1% |
| Obliterative Bronchiolitis |
2.1% |
| Renal Transplant |
2.1% |
| Polycythaemia |
1.6% |
| Copd |
1.1% |
| Copd Exacerbation |
1.1% |
| Dyspnoea |
1.1% |
|
| Drug Interaction |
16.3% |
| Rhabdomyolysis |
14.0% |
| Tachycardia |
9.3% |
| Myalgia |
7.0% |
| Renal Impairment |
7.0% |
| Toxicity To Various Agents |
7.0% |
| Asthma |
4.7% |
| Immunosuppressant Drug Level Increased |
4.7% |
| Supraventricular Tachycardia |
4.7% |
| Emotional Distress |
2.3% |
| Epistaxis |
2.3% |
| Feeling Abnormal |
2.3% |
| Feeling Hot |
2.3% |
| Gout |
2.3% |
| Hypokalaemia |
2.3% |
| Medication Error |
2.3% |
| Nervousness |
2.3% |
| Oesophageal Candidiasis |
2.3% |
| Overdose |
2.3% |
| Respiratory Disorder |
2.3% |
|
